A Clinical Study Exploring CT1194C in Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma

NCT07068906 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

27

Enrollment

OTHER

Sponsor class

Conditions

B-Cell Non-Hodgkin Lymphoma

Interventions

DRUG: CAR-T cells chimenric antigen receptor T cells

Sponsor

Institute of Hematology & Blood Diseases Hospital, China